Hypoxia and therapeutic treatment of EV-A71 with an immune modulator TLR7 agonist in a new immunocompetent mouse model
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1423-0127
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Hypoxia and therapeutic treatment of EV-A71 with an immune modulator TLR7 agonist in a new immunocompetent mouse model ; volume:26 ; number:1 ; day:11 ; month:11 ; year:2019 ; pages:1-14 ; date:12.2019
Journal of biomedical science ; 26, Heft 1 (11.11.2019), 1-14, 12.2019
- Urheber
-
Liou, An-Ting
Liao, Chun-Che
Chou, Shu-Fan
Chang, Ya-Shu
Chang, Chih-Shin
Shih, Chiaho
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s12929-019-0585-y
- URN
-
urn:nbn:de:101:1-2020030822404849975723
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:55 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Liou, An-Ting
- Liao, Chun-Che
- Chou, Shu-Fan
- Chang, Ya-Shu
- Chang, Chih-Shin
- Shih, Chiaho
- SpringerLink (Online service)
Ähnliche Objekte (12)
Deoxyguanosine is a TLR7 agonist
Intratumoral immunotherapy with the TLR7/8 agonist 3M-052
The TLR7 agonist Imiquimod promote the immunogenicity of msenchymal stem cells
Migrationsverhalten von NK-Zellen nach Stimulation mit dem TLR7-Agonisten Resiquimod
Lignin-chitosan-based biocomposite film for the localized delivery of TLR7 agonist imiquimod
T cell-independent eradication of experimental glioma by intravenous TLR7/8-agonist-loaded nanoparticles
Whole blood targeting and activation of monocytes with TLR7 agonist formulated in cationic liposomes
TLR7/8 agonist induces a post-entry SAMHD1-independent block to HIV-1 infection of monocytes
Gastric cancer vaccines synthesized using a TLR7 agonist and their synergistic antitumor effects with 5-fluorouracil
Development of a TLR7/8 agonist adjuvant formulation to overcome early life hyporesponsiveness to DTaP vaccination
Hypoxia impairs agonist-induced integrin αIIbβ3 activation and platelet aggregation
In-vitro Modulation of mTOR-HIF-1α Axis by TLR7/8 Agonist (Resiquimod) in B-Chronic Lymphocytic Leukemia
Deoxyguanosine is a TLR7 agonist
Intratumoral immunotherapy with the TLR7/8 agonist 3M-052
The TLR7 agonist Imiquimod promote the immunogenicity of msenchymal stem cells
Migrationsverhalten von NK-Zellen nach Stimulation mit dem TLR7-Agonisten Resiquimod
Lignin-chitosan-based biocomposite film for the localized delivery of TLR7 agonist imiquimod
T cell-independent eradication of experimental glioma by intravenous TLR7/8-agonist-loaded nanoparticles
Whole blood targeting and activation of monocytes with TLR7 agonist formulated in cationic liposomes
TLR7/8 agonist induces a post-entry SAMHD1-independent block to HIV-1 infection of monocytes
Gastric cancer vaccines synthesized using a TLR7 agonist and their synergistic antitumor effects with 5-fluorouracil
Development of a TLR7/8 agonist adjuvant formulation to overcome early life hyporesponsiveness to DTaP vaccination
Hypoxia impairs agonist-induced integrin αIIbβ3 activation and platelet aggregation
In-vitro Modulation of mTOR-HIF-1α Axis by TLR7/8 Agonist (Resiquimod) in B-Chronic Lymphocytic Leukemia
Deoxyguanosine is a TLR7 agonist
Intratumoral immunotherapy with the TLR7/8 agonist 3M-052
The TLR7 agonist Imiquimod promote the immunogenicity of msenchymal stem cells
Migrationsverhalten von NK-Zellen nach Stimulation mit dem TLR7-Agonisten Resiquimod
Lignin-chitosan-based biocomposite film for the localized delivery of TLR7 agonist imiquimod
T cell-independent eradication of experimental glioma by intravenous TLR7/8-agonist-loaded nanoparticles
Whole blood targeting and activation of monocytes with TLR7 agonist formulated in cationic liposomes
TLR7/8 agonist induces a post-entry SAMHD1-independent block to HIV-1 infection of monocytes
Gastric cancer vaccines synthesized using a TLR7 agonist and their synergistic antitumor effects with 5-fluorouracil
Development of a TLR7/8 agonist adjuvant formulation to overcome early life hyporesponsiveness to DTaP vaccination
Hypoxia impairs agonist-induced integrin αIIbβ3 activation and platelet aggregation